Robert Bindert Huizinga Net Worth & Insider Trades

Robert Bindert Huizinga - EVP Research, Aurinia Pharmaceuticals Inc

As of March 4, 2022

What is Robert Bindert Huizinga's Net Worth?

The current estimated net worth of Aurinia Pharmaceuticals Inc's EVP Research, Robert Bindert Huizinga, is estimated to be about $7.25M . Robert Bindert Huizinga owns about 69,379 units of Aurinia Pharmaceuticals Inc common stock. In the last year at Aurinia Pharmaceuticals Inc, Robert Bindert Huizinga has sold an estimated value of $5.48M worth.

What is Robert Bindert Huizinga's Past Insider Trading?

Robert Bindert Huizinga's largest purchase order was 95,000 units , worth over $304K on October 26, 2021. Robert Bindert Huizinga's largest sale order was 130,000 units , worth over $3.87M on October 26, 2021. In total, Robert Bindert Huizinga has made about 6 transactions over a year of their time at Aurinia Pharmaceuticals Inc. Robert Bindert Huizinga usually trades in September, with the busiest year in 2021. The most recent transaction was a sale order of 4,849 units , worth over $58.24K on March 4, 2022.

Robert Bindert Huizinga

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Robert Bindert Huizinga's Salary in 2020?

As EVP Research of Aurinia Pharmaceuticals Inc, Robert Bindert Huizinga has a total base salary of $72,081 . Robert Bindert Huizinga received compensation valued at about $3,562,379 in 2020 after becoming EVP Research. The vast majority of their compensation came in the form of a bonus of $75,684 , stock awards of $461,040 , option awards of $2,907,909 , other earnings, plans or compensations of $43,249 , and other compensation of $2,416 .

What is Robert Bindert Huizinga's' Mailing Address?

  • Mailing address is #1203-4464 Markham Street Victoria A1 BC V8Z7X8 British Columbia, Canada

Aurinia Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Peter Greenleaf 2020 $673,400 - $1,534,992 $7,753,906 $707,070 $9,500 $10,678,868
Peter Greenleaf 2019 $438,258 $250,000 - $4,176,172 $368,137 $4,063 $5,236,630
Peter Greenleaf 2018 - - - - - - -
Joe Miller 2020 $279,545 $162,898 $461,040 $2,639,722 $167,727 $4,100 $3,715,032
Joe Miller 2019 - - - - - - -
Joe Miller 2018 - - - - - - -
Dennis Bourgeault 2020 $88,426 - - $399,825 $121,992 $93,472 $703,715
Dennis Bourgeault 2019 $270,145 - - $180,784 $126,205 $3,713 $580,847
Dennis Bourgeault 2018 $242,969 - - $351,432 $86,220 - $680,621
Max Colao 2020 $354,167 $153,125 $461,040 $3,664,488 $212,500 - $4,845,320
Max Colao 2019 - - - - - - -
Max Colao 2018 - - - - - - -
Max Donley 2020 $383,320 - $461,040 $2,249,253 $239,575 $4,615 $3,337,803
Max Donley 2019 $168,299 - - $598,154 $177,600 $1,850 $945,903
Max Donley 2018 - - - - - - -
Stephen Robertson 2020 $72,081 $75,684 $461,040 $2,907,909 $43,249 $2,416 $3,562,379
Stephen Robertson 2019 - - - - - - -
Stephen Robertson 2018 - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1600620/000162828021009686/auriniapharmaceuticalsinc2.htm

What are Aurinia Pharmaceuticals Inc's Past Insider Trades?

Aurinia Pharmaceuticals Inc's most recent insider trade came on November 23, 2022 by Matthew Maxwell Donley who bought 10,000 units worth $46.6K . In the last year, insiders at Aurinia Pharmaceuticals Inc have sold an estimated value of $32.77M and bought an estimated value of $6.21M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Michael Robert Martin, Chief Business Officer,  Neil Solomons, Chief Medical Officer,  and Robert Bindert Huizinga, EVP Research .

Aurinia Pharmaceuticals Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1